Adherium Limited (ASX:ADR)
0.0040
0.00 (0.00%)
Sep 25, 2025, 3:52 PM AEST
Adherium Company Description
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases.
It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.
The company was founded in 2001 and is based in Melbourne, Australia.
Adherium Limited

Country | Australia |
Founded | 2001 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 40 |
CEO | Dawn Bitz |
Contact Details
Address: 447 Collins Street Melbourne, 3000 Australia | |
Website | adherium.com |
Stock Details
Ticker Symbol | ADR |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000ADR1 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Louis James Panaccio BEC, C.A., M.A.I.C.D. | Executive Chairman of the Board |
Emily Austin | Company Secretary |
Tom Quinlan | Caretaker Chief Financial Officer |
Angie Jones | HR Manager |
Michael Motion | Consultant |
Michael Gormack | Head of Devices |
David Haddad | Head of Product |
Jason Hochman | Head of US Commercial/GTM |
Dr. John Douglas Wilson ChB, FRACP, FRCPA, MB, Ph.D. | Executive Medical Director |